@article{ed4b657f7c824fbc8f2e550372cd7496,
title = "The burden of familial chylomicronemia syndrome from the patients{\textquoteright} perspective",
author = "Andres Gelrud and Williams, \{Karren R.\} and Andrew Hsieh and Gwosdow, \{Andrea R.\} and Alan Gilstrap and Alan Brown",
note = "ABSTRACT ABSTRACT Background: Familial chylomicronemia syndrome (FCS) is a rare, inherited lipid disorder characterized by high levels of plasma triglycerides and chylomicrons, which may cause life-threatening acute pancreatitis. Currently no FDA-approved treatment exists. Management is low-fat diet (<20g fat/day), which is difficult to maintain. With the restricted diet, triglycerides may remain elevated.",
year = "2017",
month = nov,
day = "2",
doi = "10.1080/14779072.2017.1372193",
language = "American English",
volume = "15",
journal = "Expert review of cardiovascular therapy",
}